Intervention Review

You have free access to this content

Retinoids for preventing the progression of cervical intra-epithelial neoplasia

  1. C. William Helm1,*,
  2. Douglas J Lorenz2,
  3. Nicholas J Meyer3,
  4. William WR Rising4,
  5. Judith L Wulff5

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 6 JUN 2013

Assessed as up-to-date: 22 APR 2013

DOI: 10.1002/14651858.CD003296.pub3


How to Cite

Helm CW, Lorenz DJ, Meyer NJ, Rising WWR, Wulff JL. Retinoids for preventing the progression of cervical intra-epithelial neoplasia. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD003296. DOI: 10.1002/14651858.CD003296.pub3.

Author Information

  1. 1

    Queen Elizabeth Hospital, Northern Gynaecological Oncology Centre, Gateshead, Tyne and Wear, UK

  2. 2

    University of Louisville, Department of Bioinformatics and Biostatistics, School of Public Health and Information Science, Louisville, Kentucky, USA

  3. 3

    Johnston City Community Health Center, Illinois, USA

  4. 4

    StataCorp LP, College Station, Texas, USA

  5. 5

    University of Louisville, Kornhauser Health Sciences Library, Louisville, KY, USA

*C. William Helm, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Sheriff Hill, Gateshead, Tyne and Wear, NE9 6SX, UK. cwilliamhelm@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 6 JUN 2013

SEARCH

[Analysis 1.1]
Analysis 1.1. Comparison 1 Regression of CIN2/3 with retinoid versus control, Outcome 1 Complete or partial regression of CIN2/3 at 3-12 months.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Regression of CIN2/3 with retinoid versus control, Outcome 2 Complete regression of CIN2/3 at 9-27 months.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Regression of CIN2/3 with retinoid versus control, Outcome 3 Complete regression of CIN2 at 9-27 months.